1W Return
1M Return
6M Return
1Y Return
3Y Return
Start SIP in Oxygenta Pharmaceutical
Oxygenta Pharmaceutical Stock Performance
52 Week Low - High
Today’s Low - High
Open
Prev. Close
Total Traded Value
Oxygenta Pharmaceutical Fundamental
Market Cap (in crs)
Face Value
Turnover (in lacs)
Key Metrics
Qtr Change %
26.77% Fall from 52W High
-12.6
Dividend yield 1yr %
0
Oxygenta Pharmaceutical Technical Analysis
Moving Averages Analysis
Moving Averages Analysis
Current Price
5Day EMA
79.20
10Day EMA
78.90
12Day EMA
78.80
20Day EMA
78.80
26Day EMA
79.00
50Day EMA
79.90
100Day EMA
78.30
200Day EMA
69.70
5Day SMA
79.20
10Day SMA
79.00
20Day SMA
77.40
30Day SMA
78.90
50Day SMA
79.90
100Day SMA
82.60
150Day SMA
77.80
200Day SMA
66.80
Delivery & Volume
| Period | Combined Delivery Volume | NSE+BSE Traded Volume |
|---|---|---|
Day Rs | 294 Rs | 294 Rs |
Week Rs | 3408 Rs | 3408 Rs |
Month Rs | 3392 Rs | 3392 Rs |
Resistance & Support
78.71
Pivot
Resistance
First Resistance
80.43
Second Resistance
81.29
Third Resistance
83.01
Support
First Support
77.85
Second support
76.13
Third Support
75.27
Relative Strength Index
51.03
Money Flow Index
34.57
MACD
-0.25
MACD Signal
-0.63
Average True Range
2.90
Average Directional Index
13.72
Rate of Change (21)
2
Rate of Change (125)
31.90
Similar stocks
Similar Stocks
Peer comparison
Compare
| Company | Market Price | Market Cap | 52W Low | 52W High |
|---|---|---|---|---|
282.78 | 72.51 | 202.8 | ||
Ambalal Sarabhai Enterprises Ltd. | - | - | - | |
Oxygenta Pharmaceutical Ltd. | - | - | - | |
Sanjivani paranteral Ltd. | - | - | - | |
Gennex Laboratories Ltd. | - | - | - | |
Fredun Pharmaceuticals Ltd. | - | - | - | |
Trident Lifeline Ltd. | - | - | - |
Oxygenta Pharmaceutical Latest News
Oxygenta Pharmaceutical Company background
Founded in: 1990
Managing director: Sai Sudhakar Vankineni
Oxygenta Pharmaceutical Limited (Formerly known S S Organics Ltd) was incorporated as Private Limited Company in year 1990 and converted into a Limited Company in 1993, with the objective of carrying on the business of manufacturing all classes and kinds of Drugs including Pharmaceutical preparation, and Organic Fine Chemicals. Later, the Company changed its name from S.S. Organics Ltd. to Oxygenta Pharmaceutical Limited in 202122.The Company is strong in manufacturing of anti ulcerative and anti bacterial drugs. The Company is doing contract manufacturing work for APL and also having its own production. The Company is engaged in manufacture of bulk drugs. It manufactures a wide range of new generation quinolones, antiasthmatic, antiulcerant, and antiinflammatory drugs. The Company has plant located at Medak in Andhra Pradesh. The Company has been doing contract manufacturing work with APL for manufacturing of Cirprofloxacin HCL from QAcid and has been manufacturing Pantaprozole Sodium and Gabapentine for own production. To minimize the working capital requirement and to have consistent income, it is necessary to continue contract manufacturing work till the Company gets working capital limits from any Bank. This contract manufacturing helps it to meet major operational expenses of the Company. Since the Company started commercial production in July, 2015 after fire accident, it is in the process of stabilizing the manufacturing and marketing.
Oxygenta Pharmaceutical FAQs
What is the Mutual Fund shareholding in Oxygenta Pharmaceutical ?
The Mutual Fund Shareholding in Oxygenta Pharmaceutical was 0.03% at the end of .
How to buy Oxygenta Pharmaceutical shares?
You can easily buy Oxygenta Pharmaceutical shares in Kotak Securities by opening a demat account and getting the KYC documents verified online.
Please be aware that Oxygenta Pharmaceutical stock prices are subject to continuous fluctuations due to various factors.
Open Demat Account
